Podcast Episode Details
Back to Podcast Episodes
An Interview With Kfir Oved, CEO of Canopy Biotech, Which is Pursuing Novel Treatments in MG
Season 1 Episode 186
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Kfir Oved about the latest Israeli research on myasthenia gravis.
Published on 4 months, 1 week ago